Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Robert O. Williams$suffix/text()$suffix/text(), Akshaya M. Patel, Melisa K. Barron & True L. Rogers. (2001) Investigation of Some Commercially Available Spacer Devices for the Delivery of Glucocorticoid Steroids from a pMDI. Drug Development and Industrial Pharmacy 27:5, pages 401-412.
Read now
Read now
F. Vanderbist, B. Wery, D. Baran, B. Van Gansbeke, A. Schoutens & A. J. Moës. (2001) Deposition of Nacystelyn from a Dry Powder Inhaler in Healthy Volunteers and Cystic Fibrosis Patients. Drug Development and Industrial Pharmacy 27:3, pages 205-212.
Read now
Read now
AnthonyJ. Hickey. (1993) Lung Deposition and Clearance of Pharmaceutical Aerosols: What Can Be Learned from Inhalation Toxicology and Industrial Hygiene?. Aerosol Science and Technology 18:3, pages 290-304.
Read now
Read now
P. R. Byron. (1986) Some Future Perspectives for Unit Dose Inhalation Aerosols. Drug Development and Industrial Pharmacy 12:7, pages 993-1015.
Read now
Read now
Articles from other publishers (26)
Iain McGilveray. 2012. Encyclopedia of Biopharmaceutical Statistics, Third Edition. Encyclopedia of Biopharmaceutical Statistics, Third Edition
170
185
.
Michael Hindle & P Worth Longest. (2012) Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device. Journal of Pharmacy and Pharmacology 64:9, pages 1254-1263.
Crossref
Crossref
IGOR GONDA. (1981) A semi-empirical model of aerosol deposition in the human respiratory tract for mouth inhalation. Journal of Pharmacy and Pharmacology 33:1, pages 692-696.
Crossref
Crossref
I Gonda. (1981) Study of the Effects of Polydispersity of Aerosols on Regional Deposition in the Respiratory Tract. Journal of Pharmacy and Pharmacology 33:Supplement_1, pages 52P-52P.
Crossref
Crossref
M.-H. Becquemin & J.-P. Chaumuzeau. (2010) Inhaled insulin: A model for pulmonary systemic absorption?. Revue des Maladies Respiratoires 27:8, pages e54-e65.
Crossref
Crossref
Shein-Chung ChowIain J. McGilveray. 2010. Encyclopedia of Biopharmaceutical Statistics. Encyclopedia of Biopharmaceutical Statistics
170
185
.
J Morris. 2009. International Pharmaceutical Product Registration, Second Edition. International Pharmaceutical Product Registration, Second Edition
184
209
.
M.-H. Becquemin & J.-P. Chaumuzeau. (2008) L’insuline par voie inhalée : un modèle pour l’absorption systémique pulmonaire ?. Revue des Maladies Respiratoires 25:2, pages 209-222.
Crossref
Crossref
Igor Gonda. (2006) Systemic Delivery of Drugs to Humans via Inhalation. Journal of Aerosol Medicine 19:1, pages 47-53.
Crossref
Crossref
Lee M. Nagao, Svetlana Lyapustina, Melinda K. Munos & Mary Devlin Capizzi. (2005) Aspects of Particle Science and Regulation in Pharmaceutical Inhalation Drug Products. Crystal Growth & Design 5:6, pages 2261-2267.
Crossref
Crossref
David Thompson & Anthony Hickey. 2003. Pharmaceutical Inhalation Aerosol Technology, Second Edition. Pharmaceutical Inhalation Aerosol Technology, Second Edition.
Timothy Crowder. 2003. A Guide to Pharmaceutical Particulate Science. A Guide to Pharmaceutical Particulate Science.
Susanna Wu-Pong & Peter R. Byron. (1996) Airway-to-biophase transfer of inhaled oligonucleotides. Advanced Drug Delivery Reviews 19:1, pages 47-71.
Crossref
Crossref
Ralph W. Niven & Joseph D. Brain. (1994) Some functional aspects of air-jet nebulizers. International Journal of Pharmaceutics 104:1, pages 73-85.
Crossref
Crossref
R.S Pillai, D.B Yeates, I.F Miller & A.J Hickey. (1994) Controlled release from condensation coated respirable aerosol particles. Journal of Aerosol Science 25:3, pages 461-477.
Crossref
Crossref
PETER R. BYRON & JOHN S. PATTON. (1994) Drug Delivery via the Respiratory Tract. Journal of Aerosol Medicine 7:1, pages 49-75.
Crossref
Crossref
Pramod K. Gupta & Anthony J. Hickey. (1991) Contemporary approaches in aerosolized drug delivery to the lung. Journal of Controlled Release 17:2, pages 127-147.
Crossref
Crossref
Peter R. Byron, Zhuang Sun, Hirokazu Katayama & Frantisek Rypacek. (2016) Airway Retention and Pulmonary Absorption of Poly-α,β-[N(2-hydroxyethyl)-D, L-aspartamide]. Journal of Bioactive and Compatible Polymers 6:1, pages 25-35.
Crossref
Crossref
Peter R. Byron. (1990) Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung. Advanced Drug Delivery Reviews 5:1-2, pages 107-132.
Crossref
Crossref
M. DAHLBÄCK, P. WOLLMER, B. DREFELDT & B. JONSON. (1989) Controlled Aerosol Delivery During Mechanical Ventilation. Journal of Aerosol Medicine 2:4, pages 339-347.
Crossref
Crossref
M.T. Vidgren, A. K?rkk?inen, T.P. Paronen & P. Karjalainen. (1987) Respiratory tract deposition of 99mTc-labelled drug particles administered via a dry powder inhaler. International Journal of Pharmaceutics 39:1-2, pages 101-105.
Crossref
Crossref
M.T. Vidgren, A. Kärkkäinen, P. Karjalainen & T.P. Paronen. (1987) A novel labelling method for measuring the deposition of drug particles in the respiratory tract. International Journal of Pharmaceutics 37:3, pages 239-244.
Crossref
Crossref
Peter R. Byron & Anthony J. Hickey. (1987) Spinning-Disk Generation and Drying of Monodisperse Solid Aerosols with Output Concentrations Sufficient for Single-Breath Inhalation Studies. Journal of Pharmaceutical Sciences 76:1, pages 60-64.
Crossref
Crossref
Peter R. Byron. (1986) Prediction of Drug Residence Times in Regions of the Human Respiratory Tract Following Aerosol Inhalation. Journal of Pharmaceutical Sciences 75:5, pages 433-438.
Crossref
Crossref
Igor Gonda, Ahmed Farid Abd El Khalik & Adam Z. Britten. (1985) Hexamethylmelamine aerosols prepared in an evaporation-condensation generator. International Journal of Pharmaceutics 27:2-3, pages 255-265.
Crossref
Crossref
I Gonda, C.D Judd & D.D Cooke. (1979) Monodisperse submicron glycerine aerosols. Journal of Colloid and Interface Science 68:2, pages 396-397.
Crossref
Crossref